Your browser doesn't support javascript.
loading
Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis.
Chan, Wee-Lee; Chong, Vanessa Cui Lian; Wee, Ian Jun Yan; Poon, Li Mei; Chan, Esther Hian Lee; Lee, Joanne; Chee, Yen-Lin; Jeyasekharan, Anand D; Chng, Wee-Joo; Samuel, Miny; de Mel, Sanjay.
Affiliation
  • Chan WL; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Chong VCL; Department of Haematology, Tan Tock Seng Hospital, Singapore, Singapore.
  • Wee IJY; Department of Surgery, Singapore General Hospital, Singapore, Singapore.
  • Poon LM; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Chan EHL; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Lee J; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Chee YL; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Jeyasekharan AD; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Chng WJ; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Samuel M; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • de Mel S; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
Blood Cancer J ; 13(1): 140, 2023 09 07.
Article de En | MEDLINE | ID: mdl-37679351

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Macroglobulinémie de Waldenström Type d'étude: Clinical_trials / Guideline / Systematic_reviews Limites: Humans Langue: En Journal: Blood Cancer J Année: 2023 Type de document: Article Pays d'affiliation: Singapour

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Macroglobulinémie de Waldenström Type d'étude: Clinical_trials / Guideline / Systematic_reviews Limites: Humans Langue: En Journal: Blood Cancer J Année: 2023 Type de document: Article Pays d'affiliation: Singapour